Products of lipid peroxidation (malonaldehyde, Schiff-bases) were detected in human skin. These products were increased after UV-light exposition, on chronically sun-exposed areas as well as with advancing age. Malonaldehyde cross linked epidermal glucose-6-phosphate-dehydrogenase and diminished their activity.
Yeast PFK had a sedimentation coefficient of 16.7 S both in the absence and in the presence of ATP, and did not dissociate even at very low protein concentrations. Sodium dodecyl-sulphate caused dissociation of the protein to subunits of 3.2 S.The effects of pH on substrate affinities are described. In the presence of UTP, acting as non-inhibiting phosphate donor, the behaviour of the enzyme towards F-6-P was co-operative, with a Hill coefficient of 2.2.
Yeast phosphofructokinase binds to Blue Dextran 2000@ with remarkable high affinity. Whereas phosphofructokinase from muscle and erythrocytes also have high affinity t o Blue Dextran, aldolase, hexokinase, pyruvate kinase from muscle and glyceraldehyde-3-phosphate dehydrogenase show no affinity to this chromophore.The chromophoric component of Blue Dextran seems to be responsible for these interactions, because chromophore-free dextran 2000 does not show any affinity to phosphofructokinases.Blue Dextran immobilized by fixation in cross-linked polyacrylamide gel can be used as a valuable tool for affinity chromatography of phosphofructokinase. The conditions of binding, namely pH dependence, effects of ionic strength and of enzyme effectors have been studied using gel-fixed phosphofructokinase. ATP (2-3 mM) but not ITP (up to 5 mM) specifically splits the enzyme chromophore complex.With
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.